Sign in Register

Drug class

Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type

The phrase "Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type" represents an administrative or compendial formulary grouping rather than a single standardized pharmacological drug class. Read more about Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type

151 drugs in this class 76 manufacturers

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs Smoking CessationTop indication · 45 prescription drugs

Showing 64–72 of 151 drugs

Sort

BUPROPION HCL SR (bupropion HCl)

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER

SUN PHARMA GLOB

BUPROPION HCL SR (bupropion HCl)

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER

Actavis Pharma

WELLBUTRIN SR (bupropion HCl)

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER

GSK

QUIT 2 (nicotine polacrilex)

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION

KIRKLAND-COSTCO

QUIT 2 (nicotine polacrilex)

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION

KIRKLAND-COSTCO

QUIT 4 (nicotine polacrilex)

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION

KIRKLAND-COSTCO

QUIT 4 (nicotine polacrilex)

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION

KIRKLAND-COSTCO

NICOTINE

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION

APOTEX CORP

NICOTINE (POLACRILEX) (nicotine polacrilex)

SMOKING DETERRENTS - NICOTINIC OR BUPROPION (NDRI)-TYPE · SMOKING CESSATION

KROGER CO

Filter & compare in the drug finder → Opens the drug finder with Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type preselected. Add indication or manufacturer filters there.

About Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type.

The phrase "Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type" represents an administrative or compendial formulary grouping rather than a single standardized pharmacological drug class.

It aggregates distinct therapeutic modalities used as pharmacotherapies for tobacco use disorder and smoking cessation: nicotine replacement therapy and non-nicotine oral therapy.

Nicotinic agents deliver controlled doses of nicotine to stimulate central nicotinic acetylcholine receptors and alleviate acute withdrawal symptoms, whereas bupropion acts as a norepinephrine-dopamine reuptake inhibitor and nicotinic receptor antagonist that reduces cravings and withdrawal independently of nicotine.

Clinically, these agents are indicated as aids to smoking cessation to support tobacco abstinence in adults.

ventegra.org
The phrase "Smoking Deterrents - Nicotinic or Bupropion (NDRI)-Type" represents an administrative or compendial formulary grouping rather than a single standardized pharmacological drug class
fda.gov
It aggregates distinct therapeutic modalities used as pharmacotherapies for tobacco use disorder and smoking cessation: nicotine replacement therapy and non-nicotine oral therapy
nih.gov
It aggregates distinct therapeutic modalities used as pharmacotherapies for tobacco use disorder and smoking cessation: nicotine replacement therapy and non-nicotine oral therapy
fda.gov
Nicotinic agents deliver controlled doses of nicotine to stimulate central nicotinic acetylcholine receptors and alleviate acute withdrawal symptoms, whereas bupropion acts as a norepinephrine-dopamine reuptake inhibitor and nicotinic receptor antagonist that reduces cravings and withdrawal independently of nicotine
recovered.org
Nicotinic agents deliver controlled doses of nicotine to stimulate central nicotinic acetylcholine receptors and alleviate acute withdrawal symptoms, whereas bupropion acts as a norepinephrine-dopamine reuptake inhibitor and nicotinic receptor antagonist that reduces cravings and withdrawal independently of nicotine
drugfreect.org
Nicotinic agents deliver controlled doses of nicotine to stimulate central nicotinic acetylcholine receptors and alleviate acute withdrawal symptoms, whereas bupropion acts as a norepinephrine-dopamine reuptake inhibitor and nicotinic receptor antagonist that reduces cravings and withdrawal independently of nicotine
fda.gov
Clinically, these agents are indicated as aids to smoking cessation to support tobacco abstinence in adults
cdc.gov
Clinically, these agents are indicated as aids to smoking cessation to support tobacco abstinence in adults